Abstract
Aim: The aim of this study was to examine the predictive utility of measuring health preoccupations and outcome expectancies prior to tapered benzodiazepine (BZD) withdrawal. Method: In an initial exploratory study, 44 adult participants (18–65) with a principal diagnosis of either anxiety or insomnia or both and wishing to discontinue BZD use were administered a Benzodiazepine Withdrawal Outcome Expectancy Scale (B-WOES) pre- and post-tapered withdrawal. Results: Two factors emerged from the health preoccupation section of the B-WOES: personal well-being and somatic concerns. A third subscale was derived from the section of the B-WOES measuring outcome expectancies if BZD were discontinued: an enhanced positive experience factor. A replication on a second independent sample of 38 adult participants (18–65) confirmed the three-factor structure. Conclusion: In the pooled data, the first two preoccupation subscales emerged as significant predictors of outcome following a tapered withdrawal program, so health preoccupations as well as outcome expectancies prior to discontinuation may impact on the discontinuation process.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
